Titre : Galactose

Galactose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Methicillin-Resistant Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Galactose : Questions médicales les plus fréquentes", "headline": "Galactose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Galactose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-04", "dateModified": "2025-03-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Galactose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hexose", "url": "https://questionsmedicales.fr/mesh/D006601", "about": { "@type": "MedicalCondition", "name": "Hexose", "code": { "@type": "MedicalCode", "code": "D006601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.947.875.359" } } }, "about": { "@type": "MedicalCondition", "name": "Galactose", "alternateName": "Galactose", "code": { "@type": "MedicalCode", "code": "D005690", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tilo Biedermann", "url": "https://questionsmedicales.fr/author/Tilo%20Biedermann", "affiliation": { "@type": "Organization", "name": "Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany." } }, { "@type": "Person", "name": "Eva Morava", "url": "https://questionsmedicales.fr/author/Eva%20Morava", "affiliation": { "@type": "Organization", "name": "Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. peter.witters@uzleuven.be." } }, { "@type": "Person", "name": "Scott P Commins", "url": "https://questionsmedicales.fr/author/Scott%20P%20Commins", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, North Carolina." } }, { "@type": "Person", "name": "Marianne van Hage", "url": "https://questionsmedicales.fr/author/Marianne%20van%20Hage", "affiliation": { "@type": "Organization", "name": "Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden." } }, { "@type": "Person", "name": "Michael Levin", "url": "https://questionsmedicales.fr/author/Michael%20Levin", "affiliation": { "@type": "Organization", "name": "Division of Paediatric Allergy, University of Cape Town, Cape Town, South Africa. Electronic address: Michael.levin@uct.ac.za." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37704938", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12866-023-03002-9" } }, { "@type": "ScholarlyArticle", "name": "Capillary electrophoretic methods for classification of methicillin-resistant Staphylococcus aureus (MRSA) clones.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36089316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.aca.2022.340305" } }, { "@type": "ScholarlyArticle", "name": "Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35802589", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271115" } }, { "@type": "ScholarlyArticle", "name": "Engineering a \"detect and destroy\" skin probiotic to combat methicillin-resistant Staphylococcus aureus.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36520793", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0276795" } }, { "@type": "ScholarlyArticle", "name": "Proton Motive Force Inhibitors Are Detrimental to Methicillin-Resistant Staphylococcus aureus Strains.", "datePublished": "2022-08-09", "url": "https://questionsmedicales.fr/article/35943153", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.02024-22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Sucres", "item": "https://questionsmedicales.fr/mesh/D000073893" }, { "@type": "ListItem", "position": 4, "name": "Oses", "item": "https://questionsmedicales.fr/mesh/D009005" }, { "@type": "ListItem", "position": 5, "name": "Hexose", "item": "https://questionsmedicales.fr/mesh/D006601" }, { "@type": "ListItem", "position": 6, "name": "Galactose", "item": "https://questionsmedicales.fr/mesh/D005690" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Galactose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Galactose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Galactose", "description": "Comment diagnostiquer une intolérance à la galactose ?\nQuels tests sont utilisés pour détecter la galactosémie ?\nQuels symptômes indiquent un problème avec la galactose ?\nComment évaluer le métabolisme de la galactose ?\nQuel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Galactose", "description": "Quels sont les symptômes d'une galactosémie ?\nComment se manifeste l'intolérance au galactose ?\nQuels signes indiquent une surcharge de galactose ?\nLa galactose peut-elle causer des problèmes oculaires ?\nQuels symptômes neurologiques sont associés à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Galactose", "description": "Comment prévenir la galactosémie chez les nouveau-nés ?\nLes femmes enceintes doivent-elles se soucier de la galactose ?\nQuels aliments éviter pour prévenir l'intolérance au galactose ?\nLe dépistage génétique est-il utile pour la galactosémie ?\nComment sensibiliser à la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Galactose", "description": "Quel est le traitement principal de la galactosémie ?\nPeut-on utiliser des suppléments pour la galactosémie ?\nComment gérer l'intolérance au galactose ?\nY a-t-il des médicaments pour traiter la galactosémie ?\nComment surveiller l'évolution d'une galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Galactose", "description": "Quelles complications peuvent survenir avec la galactosémie ?\nLa galactosémie peut-elle affecter le développement physique ?\nQuels risques neurologiques sont associés à la galactosémie ?\nComment la galactosémie affecte-t-elle le foie ?\nY a-t-il des complications à long terme de la galactosémie ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Galactose", "description": "Quels sont les facteurs de risque de la galactosémie ?\nLa consanguinité augmente-t-elle le risque de galactosémie ?\nLes femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?\nLes populations spécifiques sont-elles plus à risque ?\nComment les tests génétiques aident-ils à évaluer le risque ?", "url": "https://questionsmedicales.fr/mesh/D005690?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intolérance à la galactose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test de tolérance au galactose et des analyses sanguines peuvent confirmer l'intolérance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la galactosémie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des dosages de galactose dans le sang sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec la galactose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la diarrhée, les vomissements et la jaunisse peuvent indiquer un problème." } }, { "@type": "Question", "name": "Comment évaluer le métabolisme de la galactose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolisme et des analyses enzymatiques peuvent évaluer la dégradation de la galactose." } }, { "@type": "Question", "name": "Quel rôle joue l'enzyme galactose-1-phosphate uridyltransférase ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Cette enzyme est cruciale pour le métabolisme de la galactose et son absence cause des troubles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une galactosémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent vomissements, diarrhée, jaunisse et retard de croissance." } }, { "@type": "Question", "name": "Comment se manifeste l'intolérance au galactose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs abdominales, des ballonnements et des diarrhées après ingestion." } }, { "@type": "Question", "name": "Quels signes indiquent une surcharge de galactose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fatigue, des troubles neurologiques et des problèmes hépatiques peuvent apparaître." } }, { "@type": "Question", "name": "La galactose peut-elle causer des problèmes oculaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une accumulation de galactose peut entraîner des cataractes et d'autres problèmes oculaires." } }, { "@type": "Question", "name": "Quels symptômes neurologiques sont associés à la galactosémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles du développement, des convulsions et des retards mentaux peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir la galactosémie chez les nouveau-nés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage néonatal permet de détecter la galactosémie et d'initier un traitement précoce." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se soucier de la galactose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent surveiller leur consommation de galactose, surtout si des antécédents familiaux existent." } }, { "@type": "Question", "name": "Quels aliments éviter pour prévenir l'intolérance au galactose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits laitiers, les légumineuses et certains fruits comme les cerises." } }, { "@type": "Question", "name": "Le dépistage génétique est-il utile pour la galactosémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut identifier les porteurs et les personnes à risque de développer la maladie." } }, { "@type": "Question", "name": "Comment sensibiliser à la galactosémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des ressources éducatives peuvent aider à sensibiliser le public." } }, { "@type": "Question", "name": "Quel est le traitement principal de la galactosémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à suivre un régime strict sans galactose, excluant les produits laitiers." } }, { "@type": "Question", "name": "Peut-on utiliser des suppléments pour la galactosémie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de calcium et de vitamine D peuvent être nécessaires en raison d'un régime restrictif." } }, { "@type": "Question", "name": "Comment gérer l'intolérance au galactose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contenant du galactose et consulter un diététicien pour un suivi." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour traiter la galactosémie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de médicaments spécifiques, le régime est le traitement principal." } }, { "@type": "Question", "name": "Comment surveiller l'évolution d'une galactosémie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des contrôles réguliers des niveaux de galactose et des évaluations cliniques sont nécessaires." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la galactosémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des problèmes hépatiques, des cataractes et des troubles neurologiques." } }, { "@type": "Question", "name": "La galactosémie peut-elle affecter le développement physique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner un retard de croissance et des problèmes de développement physique." } }, { "@type": "Question", "name": "Quels risques neurologiques sont associés à la galactosémie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des convulsions, des retards mentaux et des troubles du comportement peuvent survenir." } }, { "@type": "Question", "name": "Comment la galactosémie affecte-t-elle le foie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hépatomégalie et des lésions hépatiques dues à l'accumulation de galactose." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme de la galactosémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme incluent des troubles cognitifs et des problèmes de vision." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la galactosémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de galactosémie et certaines mutations génétiques augmentent le risque." } }, { "@type": "Question", "name": "La consanguinité augmente-t-elle le risque de galactosémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la consanguinité peut augmenter le risque de transmission de la galactosémie." } }, { "@type": "Question", "name": "Les femmes porteuses de gènes de galactosémie doivent-elles s'inquiéter ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent transmettre le gène à leurs enfants, augmentant le risque de la maladie." } }, { "@type": "Question", "name": "Les populations spécifiques sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines populations, comme les Ashkénazes, ont un risque plus élevé de galactosémie." } }, { "@type": "Question", "name": "Comment les tests génétiques aident-ils à évaluer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques peuvent identifier les porteurs et évaluer le risque de transmission." } } ] } ] }

Sources (10000 au total)

LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.

Enzybiotics are promising alternatives to conventional antibiotics for drug-resistant infections. Exolysins, as a class of enzybiotics, show antibacterial effects against methicillin-resistant Staphyl... This study designed a chimeric exolysin by fusing the Cell-binding domain (SH3b) from Lysostaphin with the lytic domain (LYZ2) from the gp61 enzyme. Subsequently, LYZ2-SH3b was cloned and expressed in... Analysis of bioinformatics showed that LYZ2-SH3b was stable, soluble, and non-allergenic. Protein purification was performed with a 0.8 mg/ml yield for LYZ2-SH3b. The plate lysis assay results indicat... The study suggests that phage endolysins, such as LYZ2-SH3b, may represent a promising new approach to treating MRSA infections, particularly in cases where antibiotic resistance is a concern. But fur...

Pediatric Utilization of Methicillin-resistant Staphylococcus aureus Nasal Swabs for Antimicrobial Stewardship.

Methicillin-resistant Staphylococcus aureus (MRSA) can cause serious infections and empiric treatment regimens in children frequently include an anti-MRSA antibiotic. Studies in adults have demonstrat... This was a single-site, retrospective cohort study of pediatric patients admitted with a suspected infectious diagnosis who had an MNS performed during their hospitalization between June 1, 2018 and N... This study identified 172 patients who met the inclusion criteria. Eleven (6.4%) nasal swabs were positive for MRSA and 10 (5.8%) microbiological cultures from suspected sources of infection were iden... MNS has a high NPV and low PPV in children. MNS can be utilized as an antimicrobial stewardship tool to guide the safe de-escalation of anti-MRSA antibiotics in children....

Methicillin-Resistant Staphylococcus aureus Pneumatoceles in a Neonate With Sotos Syndrome : A Case Report.

Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus can lead to the formation of pneumatoceles in the lungs. Standard treatment guidelines are not available due to the rarity o... Baby H. required prolonged respiratory support and supplemental oxygen to maintain appropriate oxygen saturation parameters for infants more than 34 weeks' gestation corrected. He was found to have mu... Baby H. was a former 32.2-week gestation male infant diagnosed with pneumonia caused by necrotizing methicillin-resistant Staphylococcus aureus leading to pneumatocele formation in both lungs.... Baby H. was managed with aggressive antibiotic therapy and then was conservatively managed until he received a tracheostomy tube on day of life (DOL) 75 to prepare for discharge home.... Baby H. was discharged from the neonatal intensive care unit (NICU) on DOL 113 with a tracheostomy tube for prolonged mechanical ventilatory support and a gastrostomy tube for nutrition. Numerous foll... While methicillin-resistant Staphylococcus aureus pneumatoceles are uncommon in the NICU setting, it is important for neonatal care providers to be aware of the causes and treatment choices currently ...

Biofilm-producing ability of methicillin-resistant Staphylococcus aureus clinically isolated in China.

Staphylococcus aureus, a commensal bacterium, colonizes the skin and mucous membranes of approximately 30% of the human population. Apart from conventional resistance mechanisms, one of the pathogenic... Analyzing non-repetitive clinical isolates of MRSA collected from seven provinces and cities in China between 2014 and 2020, it was observed that 53.2% of the MRSA isolates exhibited varying degrees o... MRSA strains with biofilm production capability warrant increased vigilance....

Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.

Methicillin-resistant Staphylococcus aureus (MRSA) infections impose a considerable burden on health systems, yet there is remarkable variation in the global incidence and epidemiology of MRSA. The MA... Operational definitions of success were defined in consortium meetings to compose a balanced strain collection of successful and sporadic MRSA isolates. Isolates were subjected to antimicrobial suscep... Heterogeneity of MRSA isolate collections across countries hampered the use of a unified operational definition of success; therefore, country-specific approaches were used to establish the MACOTRA st... Our results are the strongest yet to associate MRSA antibiotic resistance profiles and antibiotic usage with the incidence of infection and successful clonal spread, which varied by country. Harmonize...